Funding Agency

Agency
National Institute of Health (NIH)
Institute
Agency for Toxic Substances and Disease Registry (ATSDR)
Type
Preventive Health Activities Regarding Hazardous Substances (U61)
Project #
5U61TS000117-04
Application #
8326980
Study Section
Special Emphasis Panel (ZTS1-SRC (99))
Project Start
2009-09-30
Project End
2014-09-29
Budget Start
2012-09-30
Budget End
2013-09-29
Support Year
4
Fiscal Year
2012
Total Cost
$136,500
Indirect Cost

  Institution

Name
American College of Medical Toxicology
Department
Type
DUNS #
825294577
City
Phoenix
State
AZ
Country
United States
Zip Code
85028

  Publications

Lee, Charles E (2013) Federal regulation of unapproved chelation products. J Med Toxicol 9:313-7
McKay Jr, Charles A (2013) Role of chelation in the treatment of lead poisoning: discussion of the Treatment of Lead-Exposed Children Trial (TLC). J Med Toxicol 9:339-43
McKay Jr, Charles A (2013) Introduction to special issue: use and misuse of metal chelation therapy. J Med Toxicol 9:298-300
Smith, Silas W (2013) The role of chelation in the treatment of other metal poisonings. J Med Toxicol 9:355-69
Ruha, Anne-Michelle (2013) Recommendations for provoked challenge urine testing. J Med Toxicol 9:318-25
Smith, Donald; Strupp, Barbara J (2013) The scientific basis for chelation: animal studies and lead chelation. J Med Toxicol 9:326-38
Kosnett, Michael J (2013) The role of chelation in the treatment of arsenic and mercury poisoning. J Med Toxicol 9:347-54
McKay Jr, Charles A (2013) Editorial: Use and misuse of metal chelation therapy. J Med Toxicol 9:301-2
McKay Jr, Charles A (2013) Public health department response to mercury poisoning: the importance of biomarkers and risks and benefits analysis for chelation therapy. J Med Toxicol 9:308-12
Brent, Jeffrey (2013) Commentary on the abuse of metal chelation therapy in patients with autism spectrum disorders. J Med Toxicol 9:370-2

Showing the most recent 10 out of 13 publications